FI51190C - Menetelmä terapeuttisesti vaikuttavien, erityisesti koronadilatooriste n N-(3,4,5-trimetoksi-kinnamoyyli)-piperatsiinijohdannaisten valmistam iseksi. - Google Patents

Menetelmä terapeuttisesti vaikuttavien, erityisesti koronadilatooriste n N-(3,4,5-trimetoksi-kinnamoyyli)-piperatsiinijohdannaisten valmistam iseksi.

Info

Publication number
FI51190C
FI51190C FI690996A FI99669A FI51190C FI 51190 C FI51190 C FI 51190C FI 690996 A FI690996 A FI 690996A FI 99669 A FI99669 A FI 99669A FI 51190 C FI51190 C FI 51190C
Authority
FI
Finland
Prior art keywords
coronadilator
cinnamoyl
trimethoxy
preparation
therapeutically active
Prior art date
Application number
FI690996A
Other languages
English (en)
Swedish (sv)
Other versions
FI51190B (fi
Inventor
Claude Fauran
Guy Raynaud
Bernard Pourrias
Michel Turin
Original Assignee
Delalande Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Delalande Sa filed Critical Delalande Sa
Application granted granted Critical
Publication of FI51190B publication Critical patent/FI51190B/fi
Publication of FI51190C publication Critical patent/FI51190C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI690996A 1968-04-03 1969-04-03 Menetelmä terapeuttisesti vaikuttavien, erityisesti koronadilatooriste n N-(3,4,5-trimetoksi-kinnamoyyli)-piperatsiinijohdannaisten valmistam iseksi. FI51190C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB06113/68A GB1218591A (en) 1968-04-03 1968-04-03 Derivatives of n-(3,4,5-trimethoxy cennamoyl) piperazine and their process of preparation

Publications (2)

Publication Number Publication Date
FI51190B FI51190B (fi) 1976-08-02
FI51190C true FI51190C (fi) 1976-11-10

Family

ID=10071423

Family Applications (1)

Application Number Title Priority Date Filing Date
FI690996A FI51190C (fi) 1968-04-03 1969-04-03 Menetelmä terapeuttisesti vaikuttavien, erityisesti koronadilatooriste n N-(3,4,5-trimetoksi-kinnamoyyli)-piperatsiinijohdannaisten valmistam iseksi.

Country Status (17)

Country Link
US (1) US3634411A (fi)
BE (1) BE730345A (fi)
BG (1) BG15397A3 (fi)
CH (1) CH498845A (fi)
CS (1) CS163733B2 (fi)
DK (1) DK123824C (fi)
FI (1) FI51190C (fi)
FR (1) FR2007372A1 (fi)
GB (1) GB1218591A (fi)
IL (1) IL31901A (fi)
IT (1) IT1036019B (fi)
LU (1) LU58316A1 (fi)
NL (1) NL147427B (fi)
NO (1) NO124312B (fi)
RO (1) RO55704A (fi)
SE (1) SE351212B (fi)
YU (1) YU33015B (fi)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2092703A1 (en) * 1970-06-10 1972-01-28 Delalande Sa 2-(1-pyrrolidinocarbonylmethyl-piperazin-4-yl) ethyl - 3,4,5-trimethoxy benzoate - having hypotensive and adrenolytic active
FR2092902A1 (en) * 1970-06-30 1972-01-28 Delalande Sa Substd propiophenone - beta (pyrrolidino carbonylmethyl)-1'-piperazin propiophenones, analgesics, hypotensives adrenolytics, noradrenolytic
FR2278340A1 (fr) * 1974-07-17 1976-02-13 Delalande Sa Nouveau derive de la n-(trimethoxy-3,4,5 cinnamoyl) piperazine, ses sels d'addition d'acides, son procede de preparation et son application en therapeutique
GB1473262A (en) * 1974-11-20 1977-05-11 Delalande Sa Derivatives of n-3,4,5-trimethoxy cinnamoyl-piperazine their process of preparation and their therapeutic application
GR71991B (fi) * 1980-01-21 1983-08-26 Delalande Sa
JPS5888370A (ja) * 1981-11-19 1983-05-26 Hokuriku Seiyaku Co Ltd １−（３，４，５−トリメトキシシンナモイル）−４−アミノカルボニルエチル置換ピペラジン及びホモピペラジン誘導体、及びその製造方法
IT1151104B (it) * 1982-02-04 1986-12-17 Delalande Sa Impiego terapeutico di derivati (1-cinnamoil oppure 1-fenetil-carbonil)piperazinici
FR2522325B1 (fr) * 1982-02-26 1985-08-09 Delalande Sa Nouveaux derives aryliques de la piperazine, de l'homopiperazine et de n,n'-dialkyl diamino-1,2 ethane, leur procede de preparation et leur application en therapeutique
FR2552762B1 (fr) * 1983-09-30 1986-07-25 Delalande Sa Nouveaux amides piperaziniques et homopiperaziniques derives de l'acide 3,4-dioxymethylene cinnamique, leur procede de preparation et leur application en therapeutique
JPS6172773A (ja) * 1984-09-17 1986-04-14 Terumo Corp ピペラジン誘導体およびこれを含有する血管拡張剤
US6011035A (en) * 1998-06-30 2000-01-04 Neuromed Technologies Inc. Calcium channel blockers
AP2005003232A0 (en) 2002-08-19 2005-03-31 Pfizer Prod Inc Combination therapy for hyperproliferative diseases.
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
ES2382009T3 (es) 2006-12-01 2012-06-04 Bristol-Myers Squibb Company Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares
AU2008277796A1 (en) * 2007-07-19 2009-01-22 F. Hoffmann-La Roche Ag Novel heterocyclyl compounds and their use as chemokine antagonists
CN101260092B (zh) * 2008-04-14 2011-07-20 罗军 马来酸桂哌齐特的制备方法
CN101723918B (zh) * 2008-10-24 2011-08-31 重庆医科大学医药研究所 马来酸桂哌齐特的制备工艺
CN101531643B (zh) * 2009-04-13 2012-11-14 上海理奥生物医药科技有限责任公司 一种改进的马来酸桂哌齐特的合成方法
CN102229583B (zh) * 2011-05-13 2013-11-27 江苏神龙药业有限公司 一种桂哌齐特的合成方法
CN103664830A (zh) * 2012-09-05 2014-03-26 凌沛学 一种马来酸桂哌齐特改进的合成方法
CN103896878B (zh) * 2012-12-26 2018-02-09 江苏万邦生化医药股份有限公司 一种桂哌齐特的纯化脱色方法
CN103245734A (zh) * 2013-01-18 2013-08-14 沈阳亿灵医药科技有限公司 一组控制马来酸桂哌齐特质量的组合物
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
WO2020150473A2 (en) 2019-01-18 2020-07-23 Dogma Therapeutics, Inc. Pcsk9 inhibitors and methods of use thereof

Also Published As

Publication number Publication date
FR2007372A1 (fi) 1970-01-09
BG15397A3 (bg) 1976-05-26
IL31901A (en) 1972-03-28
IT1036019B (it) 1979-10-30
LU58316A1 (fi) 1969-10-27
GB1218591A (en) 1971-01-06
US3634411A (en) 1972-01-11
DK123824B (fi) 1972-08-07
CS163733B2 (fi) 1975-11-07
SE351212B (fi) 1972-11-20
RO55704A (fi) 1974-01-03
NL147427B (nl) 1975-10-15
NL6905019A (fi) 1969-10-07
CH498845A (fr) 1970-11-15
YU33015B (en) 1976-03-31
BE730345A (fi) 1969-09-21
YU83469A (en) 1975-06-30
DE1915795B2 (de) 1975-07-03
DK123824C (da) 1972-12-18
NO124312B (fi) 1972-04-04
DE1915795A1 (de) 1970-09-10
FI51190B (fi) 1976-08-02
IL31901A0 (en) 1969-05-28

Similar Documents

Publication Publication Date Title
FI51190C (fi) Menetelmä terapeuttisesti vaikuttavien, erityisesti koronadilatooriste n N-(3,4,5-trimetoksi-kinnamoyyli)-piperatsiinijohdannaisten valmistam iseksi.
FI50119C (fi) Menetelmä uusien terapeuttisesti tehokkaiden N-(3-sulfamyyli-4-kloorib entsamido)-indoliinijohdannaisten valmistamiseksi.
FI52339C (fi) Menetelmä terapeuttisesti aktiivisten 1,4-dihydropyridiinijohdannaiste n valmistamiseksi.
FI49977C (fi) Menetelmä terapeuttisesti käytettävien 3-alkoksi-tianafteeni-2-karboks iamidien ja niiden 1,1-dioksidien valmistamiseksi
FI48588C (fi) Analogiamenetelmä terapeuttisesti vaikuttavien 3,4-dihydroisokinoliini johdannaisten valmistamiseksi.
FI49504C (fi) Menetelmä farmakologisesti vaikuttavien bensosykloheptaisokinoliinijoh dannaisten valmistamiseksi.
FI51342C (fi) Menetelmä uusien, terapeuttisesti vaikuttavien hydroksifenyylialkyylia miinijohdannaisten valmistamiseksi.
FI49509C (fi) Menetelmä farmakologisesti vaikuttavien 5-asemaan substituoitujen 5,10 -dihydro-11H-dibentso/b,e//1,4/deatsepiini-11-onien ja niiden suolojen valmistamiseksi.
FI51179C (fi) Menetelmä uusien hypoglykeemisesti vaikuttavien 1-(p-asyyliaminoalkyyl i-fenyylisulfonyyli)-2-imino-imidatsolidiinien valmistamiseksi.
FI49718C (fi) Menetelmä terapeuttisesti vaikuttavien 2-halogeenimetyyli-3-karbonihap poamidokinoksaliini-di-N-oksidien-(1,4) valmistamiseksi.
FI51349C (fi) Menetelmä terapeuttisesti vaikuttavien N-substituoitujen 6,7-bentsomor faanien valmistamiseksi.
FI49413C (fi) Menetelmä uusien terapeuttisesti vaikuttavien fentiatsiinijohdannaisie n valmistamiseksi.
FI50630C (fi) Menetelmä farmakologisesti vaikuttavien 2,3,4,4a-tetrahydro-10H-1,2-ok satsino (3,2-b) (1,3) bentsoksatsiini-10-onien valmistamiseksi.
FI49417C (fi) Menetelmä farmakologisesti aktiivisten 2,3-dihydro-bentsofuraani-2-kar bonihappojen valmistamiseksi.
FI46158C (fi) Menetelmä 14beta-hydroksikard-20(22)-enolidi- ja bufa-20,22-dienolidij ohdannaisten valmistamiseksi.
FI49502C (fi) Menetelmä antimidribisesti vaikuttavien N-substituoitujen 1,4-dihydro- 3-karboksi-sykloalkanokinolonien-(4) valmistamiseksi
FI52581C (fi) Menetelmä terapeuttisesti käytettävien N-(1,1-ditienyyli-propyyli-(3)) -fenyylietyyliamiinien valmistamiseksi.
FI46723C (fi) Menetelmä 1,18-dimetyyli-5alfa-H-androst-1-eenijohdannaisten valmistam iseksi.
FI50243C (fi) Menetelmä terapeuttisesti vaikuttavien N-substituoitujen 3-hydroksi-9- atsamorfinaanien valmistamiseksi.
FI43987C (fi) Menetelmä farmakologisesti tehokkaiden 10-aminoalkyyli-dibents (b,f)atsepiinijohdannaisten valmistamiseksi
FI48732C (fi) Menetelmä farmakologisesti aktiivisten 3-substituoitu-amino-1,2,3,4-te trahydrokarbatsolien valmistamiseksi.
DK131608C (da) Antikonceptionelt virksomme 3,6-substituerede 16-methyl-4-pregnen-20-on-derivater
FI46621C (fi) Menetelmä terapeuttisesti vaikuttavien 5-fenyyli-3H-1,4-bentsodiatsepi inijohdannaisten valmistamiseksi.
FI46066C (fi) Analogiamenetelmä terapeuttisesti vaikuttavien N,N-dimetyyliamino-etyy li-14beta-hydroksi-5beta-pregn-20-eeni-21-karboksylaattien valmistamis eksi.
FI49972C (fi) Menetelmä farmakologisesti aktiivisten 2,3-dihydro-bentsofuraani-2-kar bonihappojen valmistamiseksi.